Expression of TLR 2, TLR 4 and iNOS in Cervical Monocytes of Chlamydia trachomatis-infected Women and Their Role in Host Immune Response

American Journal of Reproductive Immunology

Volumn 66, Issue 6, 2011, Pages 534-543

  Agrawal, Tanvi ^a   Bhengraj, Apurb R ^a   Vats, Vikas ^a   Salhan, Sudha ^b   Mittal, Aruna ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Cervical monocytes; Chlamydia trachomatis; Genital infection; Inducible nitric oxide synthase; Toll like receptors

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CYTOKINE RELEASE; FEMALE; FEMALE GENITAL SYSTEM; FEMALE INFERTILITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; MUCOPURULENT CERVICITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVICITIS;

ADULT; CELL LINE; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENITAL DISEASES, FEMALE; HELA CELLS; HUMANS; IMMUNITY, INNATE; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 81155155482     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01064.x     Document Type: Article

References (46)

1. Gerbase AC, Rowley JT, Mertens TE: Global epidemiology of sexually transmitted diseases. Lancet 1998; 351:2-4.
2. Ridgway GL: Treatment of chlamydial genital infection. J Antimicrob Chemother 1997; 40:311-314.
3. Schachter J: Overview of C. trachomatis infection and the requirements for a vaccine. Rev Infect Dis 1985; 7:713-716.
4. Stamm WE: Chlamydia trachomatis infections: progress and problems. J Infect Dis 1999; 179:S380-S383.
5. Kimani J, Maclean IW, Bwayo JJ, MacDonald K, Oyugi J, Maitha GM, Peeling RW, Cheang M, Nagelkerke NJ, Plummer FA, Brunham RC: Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996; 173:1437-1444.
6. Holland MJ, Bailey RL, Conway DJ, Culley F, Miranpuri G, Byrne GI, Whittle HC, Mabey DC: T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996; 105:429-436.
7. Faal N, Bailey RL, Sarr I, Joof H, Mabey DC, Holland MJ: Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection. Clin Exp Immunol 2005; 142:347-353.
8. Stephens RS: The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11:44-51.
9. Brunham RC, Peeling RW: Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994; 3:218-233.
10. Ramsey KH, Sigar IM, Schripsema JH, Shaba N, Cohoon KP: Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immun 2005; 73:6962-6973.
11. Shah AA, Schripsema JH, Imtiaz MT, Sigar IM, Kasimos J, Matos PG, Inouye S, Ramsey KH: Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005; 32:49-56.
12. Medzhitov R, Janeway Jr C: The Toll receptor family and microbial recognition. Trends Microbiol 2000; 8:452-456.
13. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
14. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of Gram negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
15. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL: Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999; 285:732-736.
16. Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, Fenton MJ: The CD14 ligands lipo arabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 1999; 163:6748-6755.
17. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A: The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811-815.
18. Prebeck S, Brade H, Kirschning CJ, Da Costa CP, Durr S, Wagner H, Miethke T: The Gram-negative bacterium Chlamydia trachomatis L(2) stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin. Microbes Infect 2003; 5:463-470.
19. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M: Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168:1435-1440.
20. Ohashi K, Burkart V, Flohe S, Kolb H: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164:558-561.
21. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA: Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000; 164:13-17.
22. Prebeck S, Kirschning C, Durr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T: Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 2001; 167:3316-3323.
23. Netea MG, Kullberg BJ, Galama JM, Stalenhoef AF, Dinarello CA, Van Der Meer JW: Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol 2002; 32:1188-1195.
24. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM: Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004; 72:5799-5806.
25. Fazeli A, Bruce C, Anumba DO: Characterization of Toll-like receptors in the female reproductive tract in humans. Hum Reprod 2005; 20:1372-1378.
26. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR: Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004; 112:428-436.
27. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR: Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling. J Immunol 2002; 168:2424-2432.
28. Schaefer TM, Fahey JV, Wright JA, Wira CR: Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly (I:C). J Immunol 2005; 174:992-1002.
29. Darville T, O'Neill JM, Andrews Jr CW, Nagarajan UM, Stahl L, Ojcius DM: Toll like receptor-2, but not Toll like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171:6187-6197.
30. den Hartog JE, Lyons JM, Ouburg S, Fennema JS, de Vries HJ, Bruggeman CA, Ito JI, Peña AS, Land JA, Morré SA: TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility. Drugs Today (Barc) 2009; 45:75-82.
31. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR: Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:736-740.
32. Jacobs P, Radzioch D, Stevenson MM: In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect Immun 1996; 64:44-49.
33. Ramsey KH, Miranpuri GS, Sigar I, Ouellette MS, Byrne GI: Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 2001; 69:5131-5137.
34. Ramsey KH, Rank RG: The role of T cell subpopulations in resolution of chlamydial genital infection of mice. In Chlamydial Infections, WR Bowie, HD Caldwell, RP Jones, P-A Mardh, GL Ridgway, J Schachter, WE Stamm, ME Ward (eds). New York, Cambridge University Press, 1990, pp 241-244.
35. Ramsey KH, Sigar IM, Rana SV, Gupta J, Holland SM, Byrne GI, Morrow JD: Inducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice. Infect Immun 2003; 71:7183-7187.
36. Shao R, Zhang SX, Weijdega B, Zou S, Egecioglu E, Norström A, Brännstrom M, Billig H: Nitric oxide synthases and tubal ectopic pregnancies induced by Chlamydia infection: basic and clinical insights. Mol Hum Reprod 2010; 16:907-915.
37. Igietseme JU, Perry LL, Ananaba GA, Uriri IM, Ojior OO, Kumar SN, Caldwell HD: Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun 1998; 66:1282-1286.
38. Singh V, Rastogi S, Garg S, Kapur S, Kumar A, Salhan S, Mittal A: Polymerase chain reaction for detection of endocervical Chlamydia trachomatis infection in Indian women attending Gynecology outpatient department. Acta Cytol 2002; 46:540-544.
39. Reddy BS, Rastogi S, Verma S, Das B, Salhan S, Mittal A: Cytokine expression pattern in the genital tract of C. trachomatis women-implication for T cell responses. Clin Exp Immunol 2004; 37:552-558.
40. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141:2407-2412.
41. Cain TK, Rank RG: Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995; 63:1784-1789.
42. Ramsey KH, Rank RG: Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 1991; 59:925-931.
43. Rank RG, Ramsey KH, Pack EA, Williams DM: Effect of interferon-gamma on resolution of murine chlamydial genital infection. Infect Immun 1992; 60:4427-4429.
44. Perry LL, Feilzer K, Caldwell HD: Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 1997; 158:3344-3352.
45. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG: Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific TH1 lymphocyte clone. Reg Immunol 1993; 5:317-324.
46. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 1995; 63:3302-3308.